122 related articles for article (PubMed ID: 8100140)
1. Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Karasawa M; Omine M; Naruse T
Br J Haematol; 1993 Apr; 83(4):589-94. PubMed ID: 8100140
[TBL] [Abstract][Full Text] [Related]
2. Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin.
Janssen JW; Buschle M; Layton M; Drexler HG; Lyons J; van den Berghe H; Heimpel H; Kubanek B; Kleihauer E; Mufti GJ
Blood; 1989 Jan; 73(1):248-54. PubMed ID: 2562924
[TBL] [Abstract][Full Text] [Related]
3. Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene.
van Kamp H; Fibbe WE; Jansen RP; van der Keur M; de Graaff E; Willemze R; Landegent JE
Blood; 1992 Oct; 80(7):1774-80. PubMed ID: 1356510
[TBL] [Abstract][Full Text] [Related]
4. Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission.
Delforge M; Demuynck H; Verhoef G; Vandenberghe P; Zachée P; Maertens J; Van Duppen V; Boogaerts MA
Br J Haematol; 1998 Jul; 102(2):486-94. PubMed ID: 9695963
[TBL] [Abstract][Full Text] [Related]
5. Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.
Tsukamoto N; Morita K; Maehara T; Okamoto K; Sakai H; Karasawa M; Naruse T; Omine M
Br J Haematol; 1994 Feb; 86(2):253-8. PubMed ID: 7911034
[TBL] [Abstract][Full Text] [Related]
6. Clonality of cell populations in refractory anaemia using combined approach of gene loss and X-linked restriction fragment length polymorphism-methylation analyses.
Abrahamson G; Boultwood J; Madden J; Kelly S; Oscier DG; Rack K; Buckle VJ; Wainscoat JS
Br J Haematol; 1991 Dec; 79(4):550-5. PubMed ID: 1685326
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome in three patients with myelodysplastic syndrome showing polyclonal hematopoiesis.
Karasawa M; Tsukamoto N; Sakai H; Okamoto K; Maehara T; Naruse T; Morita K; Sato S
Acta Haematol; 1999 Mar; 101(1):46-9. PubMed ID: 10085438
[TBL] [Abstract][Full Text] [Related]
8. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
[TBL] [Abstract][Full Text] [Related]
9. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms.
Tefferi A; Thibodeau SN; Solberg LA
Blood; 1990 May; 75(9):1770-3. PubMed ID: 1970487
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
Rubio-Felix D; Giraldo P; Franco E; Gimeno J; Giralt M
Hematol Oncol; 1995; 13(3):139-52. PubMed ID: 7622144
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on clonal and non-clonal cell populations in patients with clonal hematopoietic disorders.
Ganser A; Janssen JW; Ottmann OG; Seipelt G; Eder M; Becher R; Lindermann A; Herrmann F; Schulz G; Mertelsmann R
Leukemia; 1991 Jun; 5(6):487-92. PubMed ID: 1676079
[TBL] [Abstract][Full Text] [Related]
12. [Cell clonality in myelodysplastic syndrome].
Krejcová H; Neuwirtová R; Cermák J; Belicková M; Brdicka R
Sb Lek; 2002; 103(3):339-48. PubMed ID: 12688178
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
16. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
[TBL] [Abstract][Full Text] [Related]
18. Serum tryptase measurements in patients with myelodysplastic syndromes.
Sperr WR; Stehberger B; Wimazal F; Baghestanian M; Schwartz LB; Kundi M; Semper H; Jordan JH; Chott A; Drach J; Jäger U; Geissler K; Greschniok A; Horny HP; Lechner K; Valent P
Leuk Lymphoma; 2002 May; 43(5):1097-105. PubMed ID: 12148892
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
[TBL] [Abstract][Full Text] [Related]
20. Clonality in myelodysplastic syndromes.
Weimar IS; Bourhis JH; De Gast GC; Gerritsen WR
Leuk Lymphoma; 1994 Apr; 13(3-4):215-21. PubMed ID: 7914126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
